144 related articles for article (PubMed ID: 11453076)
1. Does salmeterol increase mortality in patients with COPD?
Gerber RB; Kavuru M
Cleve Clin J Med; 2001 Jul; 68(7):600-1. PubMed ID: 11453076
[No Abstract] [Full Text] [Related]
2. A combination with clinical recommended dosages of salmeterol and ipratropium is not more effective than salmeterol alone in patients with chronic obstructive pulmonary disease.
Matera MG; Caputi M; Cazzola M
Respir Med; 1996 Sep; 90(8):497-9. PubMed ID: 8869445
[No Abstract] [Full Text] [Related]
3. Efficacy of salmeterol xinafoate in the treatment of COPD.
Mahler DA; Donohue JF; Barbee RA; Goldman MD; Gross NJ; Wisniewski ME; Yancey SW; Zakes BA; Rickard KA; Anderson WH
Chest; 1999 Apr; 115(4):957-65. PubMed ID: 10208192
[TBL] [Abstract][Full Text] [Related]
4. Alternative mechanisms for long-acting beta(2)-adrenergic agonists in COPD.
Johnson M; Rennard S
Chest; 2001 Jul; 120(1):258-70. PubMed ID: 11451847
[TBL] [Abstract][Full Text] [Related]
5. Use of a long-acting inhaled beta2-adrenergic agonist, salmeterol xinafoate, in patients with chronic obstructive pulmonary disease.
Rennard SI; Anderson W; ZuWallack R; Broughton J; Bailey W; Friedman M; Wisniewski M; Rickard K
Am J Respir Crit Care Med; 2001 Apr; 163(5):1087-92. PubMed ID: 11316640
[TBL] [Abstract][Full Text] [Related]
6. Salmeterol in smokers with COPD.
Lipworth BJ
Thorax; 1996 Jan; 51(1):110. PubMed ID: 8658361
[No Abstract] [Full Text] [Related]
7. Long-acting beta-agonists, tachyphylaxis, and corticosteroids.
Sears MR
Chest; 1996 Apr; 109(4):862-4. PubMed ID: 8635359
[No Abstract] [Full Text] [Related]
8. Salmeterol reduces dyspnea and improves lung function in patients with COPD.
Ramirez-Venegas A; Ward J; Lentine T; Mahler DA
Chest; 1997 Aug; 112(2):336-40. PubMed ID: 9266866
[TBL] [Abstract][Full Text] [Related]
9. Early reversibility to salbutamol does not always predict bronchodilation after salmeterol in stable chronic obstructive pulmonary disease.
Cazzola M; Vinciguerra A; Di Perna F; Matera MG
Respir Med; 1998 Aug; 92(8):1012-6. PubMed ID: 9893768
[TBL] [Abstract][Full Text] [Related]
10. Bronchodilator treatment in asthma. Increase in deaths during salmeterol treatment unexplained.
Sears MR; Taylor DR
BMJ; 1993 Jun; 306(6892):1610-1. PubMed ID: 8101115
[No Abstract] [Full Text] [Related]
11. Salmeterol xinafoate in asthma.
Palmer JB; Oxford JM
JAMA; 1994 Nov 23-30; 272(20):1575-6. PubMed ID: 7966861
[No Abstract] [Full Text] [Related]
12. Comparison of the effects of salmeterol and ipratropium bromide on exercise performance and breathlessness in patients with stable chronic obstructive pulmonary disease.
Patakas D; Andreadis D; Mavrofridis E; Argyropoulou P
Respir Med; 1998 Sep; 92(9):1116-21. PubMed ID: 9926165
[TBL] [Abstract][Full Text] [Related]
13. Bronchodilator treatment in asthma. Manufacturers underestimate mortality from asthma.
Inman WH
BMJ; 1993 Jun; 306(6892):1610; author reply 1611. PubMed ID: 8101116
[No Abstract] [Full Text] [Related]
14. Effects of formoterol, salmeterol or oxitropium bromide on airway responses to salbutamol in COPD.
Cazzola M; Di Perna F; Noschese P; Vinciguerra A; Calderaro F; Girbino G; Matera MG
Eur Respir J; 1998 Jun; 11(6):1337-41. PubMed ID: 9657576
[TBL] [Abstract][Full Text] [Related]
15. Inhaled salmeterol: a review of its efficacy in chronic obstructive pulmonary disease.
Jarvis B; Markham A
Drugs Aging; 2001; 18(6):441-72. PubMed ID: 11419918
[TBL] [Abstract][Full Text] [Related]
16. Salmeterol versus slow-release theophylline in patients with reversible obstructive pulmonary disease.
Taccola M; Bancalari L; Ghignoni G; Paggiaro PL
Monaldi Arch Chest Dis; 1999 Aug; 54(4):302-6. PubMed ID: 10546469
[TBL] [Abstract][Full Text] [Related]
17. Loss of bronchoprotection with salmeterol.
D'Urzo AD
Chest; 1996 Jul; 110(1):306. PubMed ID: 8681659
[No Abstract] [Full Text] [Related]
18. [efficacy and safety of salmeterol in long-term therapy in patients with chronic obstructive airway diseases].
Beeh KM; Wiewrodt R; Salem AE; Buhl R
Pneumologie; 2000 Jun; 54(6):225-31. PubMed ID: 10934892
[TBL] [Abstract][Full Text] [Related]
19. A word of caution regarding a new long-acting bronchodilator.
Bone RC
JAMA; 1994 May; 271(18):1447-8. PubMed ID: 7909854
[No Abstract] [Full Text] [Related]
20. Bronchodilator therapy in chronic obstructive pulmonary disease.
Manning HL
Curr Opin Pulm Med; 2000 Mar; 6(2):99-103. PubMed ID: 10741767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
